These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12410729)

  • 1. Is topical tacrolimus effective in alopecia areata universalis?
    Feldmann KA; Kunte C; Wollenberg A; Wolfe H
    Br J Dermatol; 2002 Nov; 147(5):1031-2. PubMed ID: 12410729
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the topical FK506 and clobetasol propionate as first-line therapy in the treatment of early alopecia areata.
    Jung KE; Gye JW; Park MK; Park BC
    Int J Dermatol; 2017 Dec; 56(12):1487-1488. PubMed ID: 28703306
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical tacrolimus: treatment failure in a patient with alopecia areata.
    Thiers BH
    Arch Dermatol; 2000 Jan; 136(1):124. PubMed ID: 10632221
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical tacrolimus in alopecia areata.
    Price VH; Willey A; Chen BK
    J Am Acad Dermatol; 2005 Jan; 52(1):138-9. PubMed ID: 15627095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of response of alopecia areata to pimecrolimus cream.
    Rigopoulos D; Gregoriou S; Korfitis C; Gintzou C; Vergou T; Katrinaki A; Kalogeromitros D
    Clin Exp Dermatol; 2007 Jul; 32(4):456-7. PubMed ID: 17537231
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic treatment for alopecia areata.
    Otberg N
    Dermatol Ther; 2011; 24(3):320-5. PubMed ID: 21689241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers.
    Hunter N; Shaker O; Marei N
    J Dermatolog Treat; 2011 Feb; 22(1):2-10. PubMed ID: 20524872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful immunsuppression in childhood alopecia areata.
    Sauerbrey A
    Klin Padiatr; 2011 Jul; 223(4):244-5. PubMed ID: 21509708
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
    Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
    Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hair growth in patients alopecia areata totalis after treatment with simvastatin and ezetimibe.
    Ali A; Martin JM
    J Drugs Dermatol; 2010 Jan; 9(1):62-4. PubMed ID: 20120427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology.
    Taylor CR; Hawk JL
    Br J Dermatol; 1995 Dec; 133(6):914-8. PubMed ID: 8547044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occlusive treatment enhances efficacy of tacrolimus 0.1% in a pediatric patient with severe alopecia areata: Case report and literature review.
    Bimbi C; Kyriakou G; Wollina U
    Pediatr Dermatol; 2021 Jan; 38(1):339-340. PubMed ID: 33247446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Changing Landscape of Alopecia Areata: An Introduction.
    Han G
    Adv Ther; 2017 Jul; 34(7):1584-1585. PubMed ID: 28646391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfasalazine for alopecia areata.
    Ellis CN; Brown MF; Voorhees JJ
    J Am Acad Dermatol; 2002 Apr; 46(4):541-4. PubMed ID: 11907504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model.
    McElwee KJ; Rushton DH; Trachy R; Oliver RF
    Br J Dermatol; 1997 Oct; 137(4):491-7. PubMed ID: 9390322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata universalis in a dog.
    Ginel PJ; Blanco B; Pérez-Aranda M; Zafra R; Mozos E
    Vet Dermatol; 2015 Oct; 26(5):379-83, e87. PubMed ID: 26123679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful hair regrowth in an acute diffuse form of alopecia areata during oral tacrolimus treatment in a patient with rheumatoid arthritis.
    Kanameishi S; Dainichi T; Endo Y; Otsuka A; Tanioka M; Kabashima K
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):e137-e138. PubMed ID: 27532876
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical cyclosporin A in alopecia areata.
    Gilhar A; Pillar T; Etzioni A
    Acta Derm Venereol; 1989; 69(3):252-3. PubMed ID: 2566234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial response of severe alopecia areata to cyclosporine A.
    Ferrando J; Grimalt R
    Dermatology; 1999; 199(1):67-9. PubMed ID: 10449964
    [No Abstract]   [Full Text] [Related]  

  • 20. Contact immunotherapy-resistant alopecia areata totalis/universalis reactive to topical corticosteroid.
    Inui S; Itami S
    J Dermatol; 2015 Sep; 42(9):937-9. PubMed ID: 26010699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.